GlassScriptPhysician profile
Adam T Wray
NPI 1497289193
$8,012.98
in general payments reported to CMS, 2019-2025
24 companies · $573 in 2025
The $573 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.52 · 2020: $141 · 2021: $428 · 2022: $6,258 · 2023: $275 · 2024: $291 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,139.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,268.42 | 2021-2024 | Da Vinci Surgical System |
| Exeltis, USA INC. | $250.27 | 2021-2025 | Slynd |
| Abbvie INC. | $229.62 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Hologic Sales and Service, LLC | $167.70 | 2021-2025 | Myosure Tissue Removal Device, Aptima |
| Organon LLC | $157.01 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $132.17 | 2024-2025 | Veozah |
| Biogen, INC. | $111.67 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $101.52 | 2020 | |
| Leo Pharma INC. | $73.74 | 2024 | Adbry |
| Conmed Corporation | $63.01 | 2021-2025 | Airseal |
| Bayer Healthcare Pharmaceuticals INC. | $58.53 | 2022 | |
| Mayne Pharma Commercial LLC | $48.67 | 2021-2023 | |
| Evofem Biosciences, INC. | $48.44 | 2022 | |
| Coopersurgical, INC. | $43.37 | 2021-2024 | Summit Doppler |
| Shield Therapeutics INC | $39.78 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $37.90 | 2025 | Ecoin Device Kit |
| Ethicon US, LLC | $37.66 | 2025 | Vistaseal, Harmonic, Enseal X1 |
| Sumitomo Pharma America, INC. | $33.19 | 2025 | Myfembree |
| Amag Pharmaceuticals, INC. | $23.84 | 2020 | |
| Nestle Healthcare Nutrition INC. | $21.63 | 2021 | |
| Merck Sharp & Dohme LLC | $20.10 | 2023 | Gardasil 9 |
| Pfizer INC. | $17.46 | 2025 | |
| Dexcom, INC. | $17.20 | 2025 | Dexcom G6 Transmitter |
| Meditrina | $10.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Wray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.